Accepted for Publication: July 19, 2021.
Published Online: September 22, 2021. doi:10.1001/jamapsychiatry.2021.2503
Corresponding Author: Donald C. Goff, MD, Department of Psychiatry, New York University Langone Medical Center, One Park Avenue, New York, NY 10016 (firstname.lastname@example.org).
Author Contributions: Drs Nemani and Goff had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Nemani, Thorpe, Goff.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Nemani, Marx.
Critical revision of the manuscript for important intellectual content: Nemani, Conderino, Thorpe, Goff.
Statistical analysis: Nemani, Conderino, Thorpe.
Administrative, technical, or material support: Marx, Goff.
Supervision: Nemani, Thorpe, Goff.
Conflict of Interest Disclosures: None reported.
S , Tzur Bitan
D , Krieger
et al. COVID-19 prevalence and mortality among schizophrenia patients: a large-scale retrospective cohort study. Schizophr Bull
. Published online February 19, 2021. doi:10.1093/schbul/sbab012Google Scholar
G , Pauly
V , Leone
et al. Disparities in intensive care unit admission and mortality among patients with schizophrenia and COVID-19: a national cohort study. Schizophr Bull
. 2021;47(3):624-634. doi:10.1093/schbul/sbaa158PubMedGoogle ScholarCrossref
M , Kristensen
KB , Pottegård
et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol
. 2020;49(5):1468-1481. doi:10.1093/ije/dyaa140PubMedGoogle ScholarCrossref
B , Carmona-Pírez
J , Ioakeim-Skoufa
et al; EpiChron Group. Baseline chronic comorbidity and mortality in laboratory-confirmed COVID-19 cases: results from the PRECOVID study in Spain. Int J Environ Res Public Health
. 2020;17(14):1-14. doi:10.3390/ijerph17145171PubMedGoogle ScholarCrossref